Vectibix Alternatives Compared
| Vectibix (panitumumab) | Oxaliplatin | Xeloda (capecitabine) |
|
|---|
| Vectibix (panitumumab) | Oxaliplatin | Xeloda (capecitabine) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Colorectal Cancer. Vectibix may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Colorectal Cancer. Oxaliplatin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Colorectal Cancer, Breast Cancer - Metastatic, Pancreatic Cancer, Stomach Cancer, Breast Cancer, Esophageal Carcinoma. Xeloda may also be used for purposes not listed in this medication guide. View more |
Related suggestions Colorectal Cancer
Popular comparisons
|
|||||||||||||||||||||||
| More about Vectibix (panitumumab) | More about Oxaliplatin | More about Xeloda (capecitabine) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Vectibix has an average rating of 7.0 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 25% reported a negative effect. |
Oxaliplatin has an average rating of 4.0 out of 10 from a total of 5 ratings on Drugs.com. 20% of reviewers reported a positive effect, while 60% reported a negative effect. |
Xeloda has an average rating of 6.6 out of 10 from a total of 32 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 28% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Vectibix side effects |
View all Oxaliplatin side effects |
View all Xeloda side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Vectibix prices |
View all Oxaliplatin prices |
View all Xeloda prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Eloxatin |
N/A |
||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
261.6 hours |
391 hours |
0.75 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 33 drugs are known to interact with Vectibix:
|
A total of 639 drugs are known to interact with Oxaliplatin:
|
A total of 294 drugs are known to interact with Xeloda:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
September 27, 2006 |
N/A |
April 30, 1998 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.